Discover a new way to find and share stories you'll love… Learn about Reading Desk

Trend Results : Heart Failure

Blog Post Results (1-20 of 2821)


New horizon in heart failure: Investigational drug poised to change cardiology?

An investigational new heart failure drug could be poised to change the face of cardiology based on Hot Line results. The new agent, known as LCZ696, has already been granted Fast Track status by the FDA -- a designation which can expedite the review of new medicines intended to treat serious or life-threatening conditions. Show More Summary

Heart drug launch could be 'most exciting ever', says Novartis

15 hours agoNews : The Newsroom

The expected launch of Novartis's new heart failure drug next year promises to be the company's most exciting ever and profit margins on the medicine will be good, its head of pharmaceuticals said on Sunday. The Swiss drugmaker impressed...Show More Summary

Tests promise 'blockbuster' new heart failure drug

An experimental drug from Swiss pharma giant Novartis reduced deaths from chronic heart failure by 20 percent compared with an existing treatment, according to the results of a vast new study. Cardiovascular failure, in which the heart does not pump blood effectively, kills at least 26 million people a year worldwide. Show More Summary

New Drug Makes Strides in Heart Failure Treatment, Study Says

Researchers announced on Saturday an experimental drug that significantly reduces the negative effects of heart failureSome are calling it "one of the biggest potential advances" against the disease in more than 10 years. Currently called...Show More Summary

Jethro Tull bassist Glenn Cornick dies

Glenn Cornick, the original bass player in the rock band Jethro Tull, died of congestive heart failure at his home in Hilo, Hawaii, on Thursday.

New Novartis Drug Shows Striking Efficacy in Treating Heart Failure

yesterdayHealth : NYT: Health

The drug reduced the risk of dying from cardiovascular causes and the risk of being hospitalized for worsening heart failure by about 20 percent in a large trial.

New Heart Drug Saves More Lives Than Standard Treatment

yesterdayHealth : Healthland

A new drug may replace the current standard of treatment for heart failure

Prevent premature deaths from heart failure, urges the Heart Failure Association

Barcelona, Saturday 30 August 2014. The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) is calling for global policy change relating to heart failure. An international white paper, Heart failure: preventing disease and death worldwide, was published in May 2014. read more

Turkey Struggling With Synthetic Drug 'Bonzai'

3 days agoHealth / Addiction : The Fix

A new form of synthetic cannabis has caused a rash of schizophrenia-like behavior and heart failure among users.

Brittany Murphy Murdered: New Lifetime Movie Suggests Actress Was Targeted, Poisoned

Brittany Murphy was murdered in 2009, a new biopic from Lifetime suggests of the death of the late actress. Murphy was found dead in her Hollywood home nearly five years ago, with her official cause of death noted as heart failure brought on by pneumonia. Her husband, Simon Montjack, would die five months later under

New implanted sensor could reduce heart failure admissions

Unexpected trips to the hospital are inconvenient and worrisome for anyone, but for congestive heart failure sufferers, they can be all too frequent. Cardiologists can now implant a new tiny, wireless monitoring sensor to help doctors and patients manage heart failure while eliminating the need for frequent surprise hospital visits.

New Implanted Sensor Could Reduce Heart Failure Admissions

Unexpected trips to the hospital are inconvenient and worrisome for anyone, but for congestive heart failure sufferers, they can be all too frequent. In a rural state like West Virginia, distance can be a factor. Cardiologists at WVU...Show More Summary

Medtronic’s Viva CRT-P with AdaptivCRT Approved in U.S.

Medtronic‘s Viva cardiac resynchronization therapy-pacemaker (CRT-P) received FDA approval for use on appropriate patients with heart failure or atrioventricular (AV) block. The device made its debut in Europe earlier this year, featuring...Show More Summary

B.K.S. Iyengar, Yoga Innovator, Dead After Long, Influential Life

last weekNews : Truthdig

The man credited with bringing yoga to the West died of heart failure Wednesday in the southern Indian city of Pune. He was 95. As the founder of Iyengar Yoga, B.K.S. Iyengar gave vast numbers of Americans and Europeans throughout the...Show More Summary

First Gene Therapy Trial Launched for Heart Patients with Mechanical Pumps

Heart failure occurs when the heart no longer pumps blood effectively. Some individuals with an advanced heart failure can be fitted with a Left Ventricular Assist Device (LVAD), which supports the failing heart and aims to restore normal blood flow. For the first time in the world, a patient with a mechanical heart pump has […]

How we cope with a cancer diagnosis starts in childhood

A baby’s smile reflects the purity in their heart.   An infant’s world is a marvelous place of possibility and love.   Children see themselves as special, capable, even omnipotent.   Time teaches failure, loss, and mortality.  How much we lose of that original perfection, that first excitement, that natural confidence, determines how we face the challenges and […]

Repeat ED visits for acute heart failure suggest need for better outpatient care

Almost one-third of acute heart failure syndrome patients seen in hospital emergency departments (EDs) in Florida and California during 2010 had ED visits during the following year, findings that suggest a lack of appropriate outpatient care. Show More Summary

Simin Behbahani, Iran’s national poet, dies at 87

Simin Behbahani, seen in this Feb. 10, 2007, file photo, was one of Iran’s most prominent writers. She died Tuesday at the age of 87. Photo by Romissa Mofidi Iran’s national poet Simin Behbahani died Tuesday of heart failure at the age...Show More Summary

Implantable Heart Devices Result in Similar Survival Benefits Among Ethnic, Racial Groups

Racial and ethnic minorities who receive implantable devices to treat heart failure derive the same substantial survival benefit from these therapies as white patients, new UCLA-led research shows. While national heart organizationsShow More Summary

Copyright © 2011 Regator, LLC